• Skip to main content
  • Skip to footer

Oklahoma Medical Research Foundation | OMRF

OMRF is an independent, nonprofit biomedical research institute dedicated to discoveries that make a difference.

  • About
    • General Information
    • Disease Research
    • Education & Outreach
    • Events
    • Careers
    • Contact Us
  • Science
    • Scientist Directory
    • Research Programs
    • Research Centers
    • Core Facilities
    • Scientific Publications
    • Scientific Seminars
    • Technology Ventures
  • News
    • Media Resources
    • News Releases
    • Publications
    • On Your Health
    • Bodywork
  • Patients
    • Anti-Aging Studies
    • Lupus (SLE)
    • MBTPS1 Related Disorders
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Sarcoidosis
    • Sjögren’s Disease
    • Other Autoimmune Disorders
  • Donate
    • Donate Now
    • Tax Credit
    • Planned Giving
    • Vehicle Donations
    • Why We Give
    • Your Gift at Work
    • Donor Recognition
    • Contact
Home - OMRF News - Archives for Floyd

Floyd

OMRF brain tumor drug receives rare disease designations from the FDA

September 2, 2020

The drug treats fast-growing, deadly brain cancers with no effective treatment.

Filed Under: News, Technology Ventures News Tagged With: 007, administration, approval, bob, Bob Floyd, brain cancer, cancer, center, childhood, diffuse intrinsic pontine glioma, dipg, drug, FDA, Floyd, glioblastoma, glioma, Oblato, Oklahoma Medical Research Foundation, okn, OKN-007, OKN007, OMRF, OUHSC, pediatric, rare pediatric disease designation, Rheal, robert, rpdd, scientist-news, stephenson, Towner

Business of Health: Teaching an old drug new tricks

February 23, 2020

Typically, a promising new experimental drug arrives on the scene with a flourish. But sometimes, it’s a long and winding road.

Filed Under: On Your Health Tagged With: cerovise, company, drug, Floyd, korea, newsok, nhpn-1010, Oblato, Prescott, robert, steve, steven, therapy, treatment

Cancer

For many cancers, the odds of survival now are better than ever and going up.

$2.4 million grant awarded to Oklahoma hearing loss project

March 1, 2012

Clinical trials for the experimental hearing loss prevention drug are being planned

Filed Under: Featured News, News, Research News Tagged With: acute acoustic event, acute acoustic trauma, David Karlman, deaf, deafness, Department of Defense, Floyd, grant, grants, hearing loss, Kopke, Otologic, Otologic Pharmaceutics, Otologics, Richard Kopke, robert floyd, VA

OMRF and Hough Ear Institute work to prevent hearing loss

December 1, 2011

A new study shows hearing loss affects 1 in 5 Americans 12 and older.

Filed Under: Featured News, News, Research News Tagged With: acute acoustic trauma, experimental treatment, Floyd, hair cells, hearing impaired, hearing loss, Hough Ear Institute, Kopke, Otologic Pharmaceutics, robert floyd, US dept of defense

OMRF scientists exploring novel breast cancer treatment

November 16, 2009

New method may keep breast cancer from spreading

Filed Under: Diseases, News Tagged With: breast, cancer, Floyd, Rheal, scientist-news, Towner

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Before Footer

EEO/AA Employer/Vet/Disabled

Footer

  • Jobs
  • Directory
  • Donor Privacy Statement
  • Intranet
Facebook Twitter Instagram Linkedin

Subscribe to OMRF News
  • Contact
  • Careers
  • Donor Privacy
  • Intranet
OMRF Logo
OKLAHOMA MEDICAL RESEARCH FOUNDATION
825 NE 13th St.
Oklahoma City, OK 73104
(405) 271-6673
Charity navigatorUnited WayGive Smart OKCTop Workplace